Imfinzi approved in the EU for the treatment of extensive-stage small cell lung cancer

This article was originally published here

SCLC is a highly aggressive, fast-growing form of lung cancer that typically recurs and progresses rapidly despite initial response to chemotherapy.1,2 The approval by the European Commission was

The post Imfinzi approved in the EU for the treatment of extensive-stage small cell lung cancer appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply